about
Implication of IRF4 aberrant gene expression in the acute leukemias of childhoodIdentification of common differentially expressed genes in urinary bladder cancerPeripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in manMicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknownSpotlight on differentially expressed genes in urinary bladder cancer.AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPKGlucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators.Drugs acting on homeostasis: challenging cancer cell adaptation.Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidneyMicrorna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasmsElucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.Serum kisspeptin concentrations are negatively correlated with body mass index in adolescents with anorexia nervosa and amenorrhea.Aberrant AML1 gene expression in the diagnosis of childhood leukemias not characterized by AML1-involved cytogenetic abnormalities.Fractal dimensions of in vitro tumor cell proliferation.Pathway simulations in common oncogenic drivers of leukemic and rhabdomyosarcoma cells: a systems biology approach.miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.Socioeconomical Factors Associated With Pediculosis (Phthiraptera: Pediculidae) in Athens, Greece.HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival.Proliferation versus regeneration: the good, the bad and the ugly.Gene expression is highly correlated on the chromosome level in urinary bladder cancer.Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?Implication of RAF and RKIP genes in urinary bladder cancer.Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.Dysregulated placental microRNAs in Early and Late onset Preeclampsia.Iron chelation with deferasirox for the treatment of secondary hemosiderosis in pediatric oncology patients: a single-center experience.Antioxidant Properties of Crocus Sativus L. and its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer's And Parkinson's disease.Stress and inflammatory biomarkers and symptoms are associated with bioimpedance measures.Inter-Tissue Expression Patterns of the Key Metabolic Biomarker Pgc1a In Severely Obese Individuals: Implication in Obesity-Induced DiseaseTumor-Suppressing Properties of Crocus sativus L.: Nature as an Anti-Cancer AgentTime‑dependent and independent effects of thyroid hormone administration following myocardial infarction in ratsThe role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysisThe Protective Role of Crocus Sativus L. (Saffron) Against Ischemia- Reperfusion Injury, Hyperlipidemia and Atherosclerosis: Nature Opposing Cardiovascular DiseasesOmalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-MorbiditiesGene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and UpdateMicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact
P50
Q21090722-062B8F94-65D2-4AAE-B072-F9889D5B2DA6Q21135503-D13596DE-7B3A-4954-9D18-3F2ED8795CB6Q24339476-803C47C3-9F75-4807-A969-5E86C56E5083Q28083277-4AE1ACAC-39E1-46CD-8112-358E88B89539Q33869194-F495F5F4-E440-46C5-9255-0258C72DB2EFQ34132234-806C0AB4-FCC9-4306-AEBA-A1BB0820BFB5Q34249418-753C09C5-1447-4926-B57A-F3E884FA4F00Q34500113-B1804A6C-4314-49A1-8E12-285CB37315FFQ34816101-7CD43777-CAC5-4880-9AFE-F04BE3E3B721Q35118634-400272B3-7030-49DE-9AFD-FC60C9C945A9Q35127713-496B74F8-3E42-42F3-AB3C-34408A5C347EQ35856573-35BAB9FF-4B8C-4F17-9B44-1B250B6636DFQ36642294-8A3430F3-7166-4968-AF7F-9250DE0DEDE9Q38480261-AE108F61-9830-461E-AABD-24D258DAD727Q38496557-E7364F88-0D9F-43F9-8F23-163D9CC0DF49Q38684389-77294D45-058C-4291-B032-96613EA6F313Q38710144-F1094AAC-4FBD-4DAD-87A9-DD05E75DFB28Q39393301-9C3DE559-C8BE-4833-A672-36E1E16CF7FFQ39398665-C2E68F84-48F5-4E36-922E-3EDBBFE198CDQ40058632-010765F1-AC84-4BF0-A75F-284CE9B48501Q40370757-7FEAB0F0-C791-4440-B708-D01C8080A5ACQ41683010-8EC51BEB-9325-4334-BCEB-6D4BA75C1C2BQ41822073-A7CA6721-3C48-413D-A622-979D15D325BCQ42151958-B3E58E29-85B4-4703-BE47-9C7DF02CB899Q43487784-0B15C85B-D550-4942-AAAB-64FE24927A24Q43890261-65070455-CFDB-4E86-9608-BCD81DEDA598Q47094932-4C44036F-7FB0-4A92-BF72-AFF7D3107C61Q49110048-4F95F0F4-B361-41BE-B731-9BCEA2896AE0Q49581139-DAB756DE-AD3E-4996-BAD2-9F0F9615B040Q50997339-FCEC7E5B-C88D-4957-8576-77ED2DB862D0Q52643127-85185F2C-5B32-4BDD-9D8D-B367584E2FD2Q53383618-55D2455A-89CE-4034-ACE7-D18F9BCB6B0EQ57168459-B8E63354-E82F-4397-9896-FAA032056F15Q88235070-AF78207A-599B-49F9-B651-2ED2FCF7F6DFQ88690494-51D0872A-DC15-4B7D-A21B-E6155B64FCA3Q88956526-CBAA2567-2240-4D56-94BD-B64FA79C4C61Q89306506-CF9DF45B-E1A9-4B5D-8C8B-213BE3A0143BQ89513618-516C4516-5237-49E1-8FD2-70C493F1FD23Q89799234-0035A551-025E-4093-9815-65BDFE9CCCF9Q90105433-5A189051-B183-4649-A1BA-1B59BD8366B0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
George I Lambrou
@nl
George I Lambrou
@sl
George I. Lambrou
@en
George I. Lambrou
@es
type
label
George I Lambrou
@nl
George I Lambrou
@sl
George I. Lambrou
@en
George I. Lambrou
@es
prefLabel
George I Lambrou
@nl
George I Lambrou
@sl
George I. Lambrou
@en
George I. Lambrou
@es
P1053
F-9674-2011
P106
P1153
8984058300
P21
P2456
P31
P496
0000-0001-8389-1360